Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME3-UK: Adjuvant intrapleural urokinase in malignant pleural effusion
2008-000586-26Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Jan 2009
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in malignant pleural effusion (MPE) comparing Intrapleural urokinase with Placebo intrapleural injection (2 arms). Primary endpoint: Mean daily breathlessness score over 28 days. Started Jan 2009; status: completed.
02
Drugs
urokinase
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on 2008-000586-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000586-26.